Zobrazeno 1 - 10
of 864
pro vyhledávání: '"Pitini V"'
Multiple myeloma (MM) remains an incurable disease, with little information available on its management in real-world clinical practice. The results of the present prospective, noninterventional observational study revealed great diversity in the tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::121f2e22d1623bbbe181c3f9a1e47032
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3085843
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3085843
Autor:
Mondello P; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medical College, New York, USA.; Department of Human Pathology, University of Messina, Messina, Italy.; Department of Biological and Environmental Sciences, University of Messina, Messina, Italy., Cuzzocrea S; Department of Biological and Environmental Sciences, University of Messina, Messina, Italy., Arrigo C; Department of Human Pathology, University of Messina, Messina, Italy., Pitini V; Department of Human Pathology, University of Messina, Messina, Italy., Mian M; Department of Hematology and CBMT, Ospedale di Bolzano, Bolzano, Italy., Bertoni F; Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland.
Publikováno v:
Hematological oncology [Hematol Oncol] 2020 Feb; Vol. 38 (1), pp. 106-110. Date of Electronic Publication: 2019 Nov 29.
Publikováno v:
Scopus-Elsevier
Almost 30% of follicular lymphomas (FL) present with stage I-II disease. Although the standard-of-care consists of involved-field radiotherapy (IFRT), approximately half of patients relapse usually outside the primary irradiation field. Systemic immu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::38ff58c25d3fcd1447a62dc6c2a44cc5
http://hdl.handle.net/11570/3041573
http://hdl.handle.net/11570/3041573
Publikováno v:
Scopus-Elsevier
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma entity whose prognosis for high-risk patients is poor. Aggressive salvage treatments to improve patient outcome have been unsatisfactory. Therefore, we evaluated the efficacy of yttriu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::27daecaae20b4e65683938d794a15366
http://hdl.handle.net/11570/3041575
http://hdl.handle.net/11570/3041575
Autor:
Mondello, P., Mian, M., Pitini, V., Cuzzocrea, S., Sindoni, A., Galletti, M., Mandolfino, M., Santoro, D., Mondello, S., Aloisi, C., Altavilla, G., Benvenga, S.
Publikováno v:
Current Oncology; Jun2016, Vol. 23 Issue 3, pe165-e170, 6p
Autor:
Li, Xiaodan1 (AUTHOR), Song, Dongxu1 (AUTHOR), Hao, Yingxuan1 (AUTHOR), Ren, Mingjing1 (AUTHOR), Guo, Yanhong1 (AUTHOR), Zhao, Huayan2 (AUTHOR), Wang, Yulin1 (AUTHOR), Tang, Lin1 (AUTHOR) tanglin@zzu.edu.cn
Publikováno v:
Scientific Reports. 9/9/2024, Vol. 14 Issue 1, p1-8. 8p.
Autor:
Caminati, Marco1 (AUTHOR) marco.caminati@univr.it, Brussino, Luisa2 (AUTHOR) luisa.brussino@unito.it, Carlucci, Matilde3 (AUTHOR) matilde.carlucci@aovr.veneto.it, Carlucci, Palma4 (AUTHOR) palma.carlucci@uniba.it, Carpagnano, Lucia Federica5 (AUTHOR) dr.fedecarpagnano@gmail.com, Caruso, Cristiano6,7 (AUTHOR) cristiano.caruso@policlinicogemelli.it, Cosmi, Lorenzo8,9 (AUTHOR) andrea.matucci@unifi.it, D'Amore, Simona10 (AUTHOR) simodamo@hotmail.it, Del Giacco, Stefano11 (AUTHOR) delgiac@gmail.com, Detoraki, Aikaterini12 (AUTHOR) kate.detoraki@gmail.com, Di Gioacchino, Mario13,14 (AUTHOR) digioacchino@me.com, Matucci, Andrea9 (AUTHOR), Mormile, Ilaria15 (AUTHOR) frapagra@hotmail.com, Granata, Francescopaolo15 (AUTHOR) francescawrossi@gmail.com, Guarnieri, Gabriella16 (AUTHOR) gabriella.guarnieri@gmail.com, Krampera, Mauro16 (AUTHOR) mauro.krampera@univr.it, Maule, Matteo1 (AUTHOR) matteo.maule@gmail.com, Nettis, Eustachio4 (AUTHOR) e.nettis@libero.it, Nicola, Stefania2 (AUTHOR) stefania.nicola@unito.it, Noviello, Silvia10 (AUTHOR) silvia.noviello88@gmail.com
Publikováno v:
Cells (2073-4409). Jul2024, Vol. 13 Issue 14, p1180. 28p.
Autor:
Santarpia, Mariacarmela, Costa, C., Pitini, V., Sanchez Ronco, M., Magri, I., Molina Vila, M. A., Taron, M., Rosell, R., Altavilla, Giuseppe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3978::c1b7972624acc807176278597fb292fb
http://hdl.handle.net/11570/3023382
http://hdl.handle.net/11570/3023382
Autor:
Mondello P; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medical College, New York, NY; Department of Human Pathology, University of Messina, Messina, Italy; Department of Biological and Environmental Sciences, University of Messina, Messina, Italy. Electronic address: pam2068@med.cornell.edu., Di Mirto C; Department of Human Pathology, University of Messina, Messina, Italy., Cuzzocrea S; Department of Biological and Environmental Sciences, University of Messina, Messina, Italy., Arrigo C; Department of Human Pathology, University of Messina, Messina, Italy., Mian M; Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria; Department of Hematology and CBMT, Ospedale di Bolzano, Bolzano, Italy., Pitini V; Department of Human Pathology, University of Messina, Messina, Italy.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2019 Aug; Vol. 19 (8), pp. e489-e495. Date of Electronic Publication: 2019 Apr 01.